Skip to main content
Quratis Inc. logo

Quratis Inc. — Investor Relations & Filings

Ticker · 348080 ISIN · KR7348080003 KO Manufacturing
Open in API
Filings indexed 238 across all filing types
Latest filing 2025-03-13 Earnings Release
Country KR South Korea
Listing KO 348080

About Quratis Inc.

https://www.quratis.com

Quratis Inc. is a biopharmaceutical company specializing in the research and development of vaccines and therapeutic agents for infectious diseases. The company's lead pipeline candidate is QTP101, a novel tuberculosis (TB) vaccine developed for adolescents and adults, an area with significant unmet medical needs. Quratis operates its own GMP-certified manufacturing facility, enabling the production of various biologics such as DNA plasmids, RNA, and proteins to support its development programs. The company is advancing the global commercialization of its TB vaccine through strategic partnerships and technology transfers, with notable progress in key Asian markets.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Quratis) announcing a significant change (over 30%) in revenue or profit structure. This type of disclosure is a standard regulatory requirement in the Korean market (DART system) to inform investors of material financial changes before the final audited annual report is published. Since it provides key financial highlights and reasons for the variance rather than being a full annual report or a simple announcement of a report's availability, it falls under the category of general regulatory filings. FY 2024
2025-03-13 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) between Quratis and a Chinese entity. It details the contract value, terms, and counterparty information. Since this is a specific material event announcement regarding a business contract that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2025-03-13 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Quratis. It outlines the date, location, agenda items (such as financial statement approval, auditor appointment, and remuneration limits), and details regarding the appointment of an auditor. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2025-03-13 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) titled '증권 발행결과' (Securities Issuance Result). It details the completion of a third-party capital increase (유상증자), including the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2025-03-12 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) titled '증권 발행결과' (Securities Issuance Result). It details the final outcome of a third-party capital increase (유상증자), including the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2025-03-12 Korean
최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding a 'Change in Largest Shareholder' (최대주주변경). It details the transition of the largest shareholder from 'Piece2S Korea' to 'Inventage Lab' following a third-party capital increase. This type of disclosure is a standard regulatory requirement for listed companies to inform the market of significant changes in control and ownership structure. It does not fit into specific categories like 'Director's Dealing' (which is for individual insider trades) or 'Major Shareholding Notification' (which is typically for investors reporting their own holdings). Therefore, it is classified as a general regulatory filing.
2025-03-12 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.